Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cibus, Inc. Director's Dealing 2018

Apr 17, 2018

34396_dirs_2018-04-16_36c25fce-954b-436d-b258-0ef3940dfd7d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Calyxt, Inc. (CLXT)
CIK: 0001705843
Period of Report: 2017-07-20

Reporting Person: Bowers Glenn R (Vice President of Breeding)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9040 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $3.59 2026-04-07 Common Stock (49000) Direct
Stock Option (Right to Buy) $13.29 2027-06-14 Common Stock (11760) Direct

Footnotes

F1: Includes 7,840 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and vest 15% on the first anniversary of the grant date and 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 45 months. This amended Report is being filed to include 1,200 shares of common stock which were inadvertently omitted from the original Report.

F2: The stock option to purchase shares of Calyxt, Inc. common stock ("Stock Option") was granted on April 7, 2016 and vests 20% on the first anniversary of the grant date, 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months.

F3: The Stock Option was granted on June 14, 2017 and vests 15% on the first anniversary of the grant date and 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 45 months.